Phage-essential oil synergy as an evolutionary and biophysical strategy against antimicrobial resistance
Drug Resistance Updates · 2026-09 · 88 · 101431
DOI: 10.1016/j.drup.2026.101431 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2026-09. Verfasst von D X Romero-Calle und 2 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones Industriales, Ingeniería Industrial, Facultad de Ingeniería, Universidad Mayor de San Andrés, La Paz, Bolivia; Instituto…. Hauptthemen laut MEDLINE: Bacteriophages, Oils, Volatile, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Mayor.
Abstract (Originalsprache)
The persistent challenge of global antimicrobial resistance means we can no longer rely solely on traditional small-molecule monotherapy. While bacteriophage therapy offers surgical precision, its clinical reach is often limited by biofilm-mediated protection, as well as the rapid evolution of resistance, and stability issues. At the same time, essential oils (EOs) show promising antibacterial activity, yet their clinical use remains stalled due to toxicity and volatility concerns. In this review, we summarize key biomedical concepts underpinning phage therapy and EOs and propose a shift in perspective: reframing EOs as biophysical adjuvants designed to reshape phage-bacteria interactions rather than treating them as standalone antimicrobials. We explore how EO-driven membrane disruption can prime bacteria for phage predation, enhancing phage adsorption and potentially steering populations toward more susceptible phenotypes. Moving beyond simple mixtures, we evaluate the mechanistic evidence for phage-EO synergy. We highlight the early stage of this field: current evidence is limited to in vitro studies, with a lack of preclinical and clinical validation, and significant barriers to clinical translation. However, by treating phage-EO combinations as rationally engineered systems, our review aims to map out a strategic path toward their responsible and meaningful development in the fight against resistant infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Investigaciones Industriales, Ingeniería Industrial, Facultad de Ingeniería, Universidad Mayor de San Andrés, La Paz, Bolivia; Instituto de Investigación y Desarrollo de Procesos Químicos, Ingeniería Químic…
- Department of Infectious Diseases, The Alfred Hospital and Monash School of Translational Medicine, Monash University, Melbourne, Australia; Centre to Impact AMR, Monash University, Melbourne, Australia. Electronic addr…
- Instituto de Investigación y Desarrollo de Procesos Químicos, Ingeniería Química, Facultad de Ingeniería, Universidad Mayor de San Andrés, La Paz, Bolivia.
Förderung
- Universidad Mayor
Zitieren
APA
Romero-Calle, D. X., Gordillo Altamirano, F., & Carrasco Villanueva, C. A. (2026). Phage-essential oil synergy as an evolutionary and biophysical strategy against antimicrobial resistance. Drug Resistance Updates, 88, 101431. https://doi.org/10.1016/j.drup.2026.101431
Vancouver
Romero-Calle DX, Gordillo Altamirano F, Carrasco Villanueva CA. Phage-essential oil synergy as an evolutionary and biophysical strategy against antimicrobial resistance. Drug Resistance Updates. 2026;88:101431. doi:10.1016/j.drup.2026.101431
BibTeX
@article{RomeroCalle2026,
author = {Romero-Calle, D X and Gordillo Altamirano, F and Carrasco Villanueva, C A},
title = {Phage-essential oil synergy as an evolutionary and biophysical strategy against antimicrobial resistance},
journal = {Drug Resistance Updates},
year = {2026},
volume = {88},
pages = {101431},
doi = {10.1016/j.drup.2026.101431}
}
EUVIMED